HJ JungVice President at ST PharmSpeaker
Profile
HJ holds a degree in Chemistry from Yonsei University and completed graduate studies at the same institution. As a senior executive at ST Pharm, Asia’s leading CDMO in the field of oligonucleotides and small molecules, he has been at the forefront of the company’s global expansion and technological innovation for nearly two decades. With deep scientific expertise and sharp business insight, HJ has led the development and commercialization of cutting-edge therapeutics, reinforcing ST Pharm’s position as a regional powerhouse and a trusted global partner. His leadership continues to shape the future of the pharmaceutical industry in Asia and beyond. |
Agenda Sessions
ST Pharm's Journey as a Solution Provider for RNA-based Therapeutics: From Metric Ton Provider of ASOs and siRNAs to guide RNA, mRNA, circRNA and their Formulations
, 11:50View Session